Author(s):
Inder Kumar, Ishwar Singh, Kapil Kumar Verma, Sunny Dhiman, Priyankul Palia
Email(s):
inder.93kumar@gmail.com
DOI:
10.52711/2231-5713.2023.00019 
Address:
Inder Kumar1*, Ishwar Singh2, Kapil Kumar Verma1, Sunny Dhiman2, Priyankul Palia2
1Minerva College of Pharmacy, Indora, Distt. Kangra, HP, India.
2School of Pharmacy, Abhilashi University, Mandi, HP, India.
*Corresponding Author
Published In:
Volume - 13,
Issue - 2,
Year - 2023
ABSTRACT:
Vaginitis is a very common gynaecological problem in women of all age groups. Fluconazole chemically known as 2-(2, 4-diflurophenyl)-1, 3-bis (1H-1, 2, 4-triazole-1-yl)-2-propanol. Is a synthetic triazole derivative antifungal agent that is effective against a wide range of systemic and superficial fungal Infections. The mucoadhesive vaginal tablets were prepared by the direct compression method. FTIR had employed to study drug excipient incompatibility. The mucoadhesive vaginal tablet was evaluated for % swelling index, Muco-adhesive strength, drug content, % drug release, and Invitro Dissolution release. It was observed that more than 85% drug was released within 480 min in direct compression method formulations (FLZ1-FLZ9). Formulation FLZ3 that containing 6% of eudragit revealed maximum drug release profile up to 89.20±0.343% within 480 min, whereas formulation FLZ5 showed 87.20±0.765% drug release. The best formulation was compared with the marketed formulations for in-vitro drug release and showed almost similar drug release. Stability study shows no changes. This study may prove potential vaginal formulation of Fluconazole against bacterial vaginosis.
Cite this article:
Inder Kumar, Ishwar Singh, Kapil Kumar Verma, Sunny Dhiman, Priyankul Palia. Therapeutic Potential of Naturally Modified Mucoadhesive Fluconazole Tablets against Vaginal Infection. Asian Journal of Pharmacy and Technology. 2023; 13(2):101-4. doi: 10.52711/2231-5713.2023.00019
Cite(Electronic):
Inder Kumar, Ishwar Singh, Kapil Kumar Verma, Sunny Dhiman, Priyankul Palia. Therapeutic Potential of Naturally Modified Mucoadhesive Fluconazole Tablets against Vaginal Infection. Asian Journal of Pharmacy and Technology. 2023; 13(2):101-4. doi: 10.52711/2231-5713.2023.00019 Available on: https://ajptonline.com/AbstractView.aspx?PID=2023-13-2-5
REFERENCES:
1. Srikrishna S, Cardozo L. The vagina as a route for drug delivery: A review. Int Urogynecol J Pelvic Floor Dysfunct. 2013; 24(4):537–43.
2. Amiji M, Sarmento B. Mucoadhesive nanosystems for vaginal microbicide development : friend or foe ? Adv Rev. 2011; 3:389–99.
3. Regina R, Pereira DA, Bruschi ML. Vaginal mucoadhesive drug delivery systems. Drug Dev Ind Pharm. 2012; 38(April 2011):643–52.
4. Chore MSA, Dighade SJ. A Review on Mucoadhesive Vaginal Drug Delivery System. Int J Reserach Pharm Chem. 2020; 10(4):350–64.
5. Alawdi S, Solanki AB. Mucoadhesive Drug Delivery Systems: A Review of Recent Developments. J Sci Res Med Biol Sci. 2021; 2(1):50–64.
6. Carvalho FC, Bruschi ML, Evangelista RC, Palmira M, Gremião D. Mucoadhesive drug delivery systems Mucoadhesive drug delivery systems. Brazilian J Pharm Sci. 2010; (March):1–19.
7. Golshani S, Vatanara A, Amin M. Recent advances in oral mucoadhesive drug delivery. J Pharm Pharm Sci. 2022; 25:201-17.
8. Mali SH, Dhadde SG, Sapate BR, Gidde DN, Bagade VP. A review on floating and mucoadhesive drug delivery system. Asian J Pharm Technol. 2021; 11(3):225–30.
9. Mamatha K, Venkatesh P. A review on: mucoadhesive drug delivery systems. J Innov Appl Pharm Sci. 2022 Jan 30:32-6.
10. Yadav VK, Gupta AB, Kumar R, Yadav JS, Kumar B. Mucoadhesive polymers: means of improving the mucoadhesive properties of drug delivery system. J Chem Pharm Res. 2010; 2(5):418–32.
11. Arun Karthick R, Ramya Devi D, Vedha Hari BN. Investigation of sustained release mucoadhesive in-situ gel system of Secnidazole for the persistent treatment of vaginal infections. J Drug Deliv Sci Technol. 2018; 43:362–8.
12. Silva MM, Calado R, Marto J, Bettencourt A, Almeida AJ, Gonçalves L. Chitosan nanoparticles as a mucoadhesive drug delivery system for ocular administration. Mar Drugs. 2017; 15(12):370.
13. Patil P, Bhopale P, Saudagar RB. Intravaginal Drug Delivery System: Compherensive Approach to Vaginal Formulations. J Drug Deliv Ther. 2019; 9(5):171–4.
14. Araujo VHS, Chaves MP, Carvalho GC, Duarte JL, Chorilli M. Chitosan-based systems aimed at local application for vaginal infections. Carbohydr Polym. 2021; 117919.
15. Baloglu E, Senyıgıt ZA, Karavana SY, Vetter A, Metın DY, Polat SH, et al. In vitro evaluation of mucoadhesive vaginal tablets of antifungal drugs prepared with thiolated polymer and development of a new dissolution technique for vaginal formulations. Chem Pharm Bull. 2011; 59(8):952–8.
16. Patel A, Patel J, Patel J. Design, development and in vitro evaluation of sertaconazole mucoadhesive vaginal tablet. Der Pharmacia Lettre. 2012; 4(2):418427.